| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.021 | 0.9 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |